Taken together, this suggests that TLR4 signalling could be an additional player in the pro-inflammatory reactions that exacerbate disease progression in ALS, as shown previously in ischemic stroke [18] and Alzheimer’s disease [19]. Here, TLR4 is linked to early-onset autosomal dominant Alzheimer disease.